Atossa Genetics, Inc. (NASDAQ: ATOS), today announced the pricing of an underwritten public offering with anticipated gross proceeds of $4,000,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE